Literature DB >> 22100542

Prescription medication use among normal weight, overweight, and obese adults, United States, 2005-2008.

Brian K Kit1, Cynthia L Ogden, Katherine M Flegal.   

Abstract

PURPOSE: We sought to describe differences between normal weight, overweight, and obese adults in use of specific prescription medication classes.
METHODS: Cross-sectional analysis of prescription medication use among 9789 adults in the National Health and Nutrition Examination Survey, a nationally representative sample of the United States.
RESULTS: In 2005-2008, 56.4% (95% confidence interval [CI], 54.6-58.3) of adults used 1+ prescription medication. Approximately one-quarter of adults used a hypertension medication (26.1%; 95% CI, 24.5%-27.8%). The use of hypertension medications increased with increasing weight status (normal weight: 17.2%; 95% CI, 15.6%-18.8%; overweight: 24.5%, 95% CI, 22.6%-26.4%; and obese: 35.1%, 95% CI, 32.8%-37.4%). Similarly, lipid-lowering, analgesic, antidepressant, proton pump inhibitors, thyroid, diabetes, and bronchodilator medication use was greater among obese compared with normal weight adults (each p < .01). Among adults 65+ years, 72% (95% CI, 68.2%-75.8%) of men and 67.7% (95% CI, 64.3%-71.2%) of women used a hypertension medication and a majority of men (51.2%, 95% CI, 48.4%-54%) and 40.3% (95% CI, 36.8%-43.8%) of women used lipid lowering medications; the use of both was greater among obese adults compared to normal weight adults (both p < .01).
CONCLUSIONS: Obese adults in the United States use several prescription medication classes more frequently, than normal weight adults, including hypertension, lipid-lowering, and diabetes medications. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100542     DOI: 10.1016/j.annepidem.2011.10.010

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  20 in total

1.  Vitamin and supplement use among old order amish: sex-specific prevalence and associations with use.

Authors:  Robert M Reed; Anna W Reed; Patrick F McArdle; Michael Miller; Toni I Pollin; Alan R Shuldiner; Nanette I Steinle; Braxton D Mitchell
Journal:  J Acad Nutr Diet       Date:  2014-10-12       Impact factor: 4.910

2.  Predictors of favorable growth patterns during the obesity epidemic among US school children.

Authors:  Raquel G Hernandez; Arik V Marcell; Janelle Garcia; Ernest K Amankwah; Tina L Cheng
Journal:  Clin Pediatr (Phila)       Date:  2015-02-16       Impact factor: 1.168

3.  Overall prescription medication use among adults: findings from the Survey of the Health of Wisconsin.

Authors:  Jianhong Che; Kristen C Malecki; Matthew C Walsh; Andrew J Bersch; Vincent Chan; Christine A McWilliams; F Javier Nieto
Journal:  WMJ       Date:  2014-12

4.  A prospective controlled study of living kidney donors: three-year follow-up.

Authors:  Bertram L Kasiske; Teresa Anderson-Haag; Ajay K Israni; Roberto S Kalil; Paul L Kimmel; Edward S Kraus; Rajiv Kumar; Andrew A Posselt; Todd E Pesavento; Hamid Rabb; Michael W Steffes; Jon J Snyder; Matthew R Weir
Journal:  Am J Kidney Dis       Date:  2015-03-17       Impact factor: 8.860

5.  The need for translational research on drug-drug interactions.

Authors:  S Hennessy; D A Flockhart
Journal:  Clin Pharmacol Ther       Date:  2012-05       Impact factor: 6.875

6.  Blood Pressure Visit Intensification in Treatment (BP-Visit) Findings: a Pragmatic Stepped Wedge Cluster Randomized Trial.

Authors:  Kevin Fiscella; Hua He; Mechelle Sanders; Andrea Cassells; Jennifer K Carroll; Stephen K Williams; Jerry Cornell; Tameir Holder; Chamanara Khalida; Jonathan N Tobin
Journal:  J Gen Intern Med       Date:  2021-08-11       Impact factor: 5.128

7.  Receipt of high risk medications among elderly enrollees in Medicare Advantage plans.

Authors:  Danya M Qato; Amal N Trivedi
Journal:  J Gen Intern Med       Date:  2012-11-06       Impact factor: 5.128

8.  Major depression, antidepressant use, and male and female fertility.

Authors:  Emily A Evans-Hoeker; Esther Eisenberg; Michael P Diamond; Richard S Legro; Ruben Alvero; Christos Coutifaris; Peter R Casson; Gregory M Christman; Karl R Hansen; Heping Zhang; Nanette Santoro; Anne Z Steiner
Journal:  Fertil Steril       Date:  2018-05       Impact factor: 7.329

9.  Blood Pressure Visit Intensification Study in Treatment: Trial design.

Authors:  Kevin Fiscella; Gbenga Ogedegbe; Hua He; Jennifer Carroll; Andrea Cassells; Mechelle Sanders; Chamanara Khalida; Brianna D'Orazio; Jonathan N Tobin
Journal:  Am Heart J       Date:  2015-09-12       Impact factor: 4.749

10.  Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study.

Authors:  Rhonda M Cooper--DeHoff; Steven T Bird; Gregory A Nichols; Joseph A Delaney; Almut G Winterstein
Journal:  J Am Heart Assoc       Date:  2013-06-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.